Download PDF
Planta Med 2013; 79(16): 1552-1557
DOI: 10.1055/s-0033-1350832
Pharmacokinetic Investigations
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Metabolism and Excretion of Kakkalide and Its Metabolites in Rat Urine, Bile, and Feces as Determined by HPLC/UV and LC/MS/MS

Hong Wang   *
1   Department of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang, China
,
Xue Bai   *
1   Department of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang, China
,
Jiahong Sun
2   Department of Pharmacology, University of North Texas Health Science Center, Fort Worth, Texas, USA
,
Yoshihiro Kano
1   Department of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang, China
,
Toshiaki Makino
3   Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan
,
Dan Yuan
1   Department of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang, China
› Author Affiliations
Further Information

Publication History

received 09 January 2013
revised 15 August 2013

accepted 19 August 2013

Publication Date:
09 October 2013 (online)

Also available at
    Permissions and Reprints

Abstract

This study investigated the metabolic fate of kakkalide (irisolidone 7-xylosylglucoside), a major isoflavone found in extracts of Pueraria lobata flowers, and in rat urine, bile, and feces. Using HPLC/UV or LC/MS/MS methods, seven metabolites, tectorigenin-7-O-glucuronide, tectorigenin-7-O-sulfate, tectorigenin-4′-O-sulfate, 6-OH biochanin A-glucuronide, irisolidone-7-O-glucuronide, tectorigenin, and irisolidone were identified in rat urine after oral administration of kakkalide. Furthermore, irisolidone-7-O-glucuronide was found in bile, and irisolidone and kakkalide were found in feces. An HPLC/UV method for simultaneous quantification of all the metabolites and kakkalide in urine, bile, and feces was developed using daidzein or apigenin as the internal standard. Over a 72-h period, 13.2 ± 2.8 % of the kakkalide was excreted as seven metabolites in urine. Over the same time period, irisolidone-7-O-glucuronide excretion in bile accounted for 3.8 ± 1.1 % of the dose, while kakkalide and irisolidone excretion in feces accounted for 2.1 ± 0.7 % and 0.7 ± 0.1 % of the dose, respectively. The results indicate that urine is the primary route of kakkalide elimination in vivo and that extensive metabolism may be one of the reasons for the low bioavailability of kakkalide.

Key words

kakkalide - Pueraria lobata - Leguminosae - excretion - pharmacokinetics - conjugate metabolites - rat

* These authors contributed equally to this work.


Supporting Information

 

  • References

  • 1 Zhang GF, Wu X, Bai X, Kano Y, Yuan D. Simultaneous determination of four isoflavone compounds in flowers of Pueraria lobata by HPLC. J Shenyang Pharm Univ 2009; 26: 40-44
    PubMedGoogle Scholar
  • 2 Yamazaki T, Nakajima Y, Niho Y. Pharmacological studies on Puerariae flos III: protective effects of kakkalide on ethanol-induced lethality and acute hepatic injury in mice. J Pharm Pharmacol 1997; 49: 831-833
    CrossrefPubMedGoogle Scholar
  • 3 Han YO, Han MJ, Park SH, Kim DH. Protective effects of kakkalide from Flos Puerariae on ethanol-induced lethality and hepatic injury are dependent on its biotransformation by human intestinal microflora. J Pharmacol Sci 2003; 93: 331-336
    CrossrefPubMedGoogle Scholar
  • 4 Lee U, Bae EA, Kim DH. Hepatoprotective effects of irisolidone on tert-butyl hyperoxide-induced liver injury. Biol Pharm Bull 2005; 28: 531-533
    CrossrefPubMedGoogle Scholar
  • 5 Shin JE, Bae EA, Lee YC, Ma JY, Kim DH. Estrogenic effect of main components kakkalide and tectoridin of Puerariae Flos and their metabolites. Biol Pharm Bull 2006; 29: 1202-1206
    CrossrefPubMedGoogle Scholar
  • 6 Park JS, Woo MS, Kim DH, Hyun JW, Kim WK, Lee JC, Kim HS. Anti-inflammatory mechanisms of isoflavone metabolites in lipopolysaccharide-stimulated microglialcells. J Pharmacol Exp Ther 2007; 320: 1237-1245
    PubMedGoogle Scholar
  • 7 Min SW, Kim DH. Kakkalide and irisolidone: HMG-CoA reductase inhibitors isolated from the flower of Pueraria thunbergiana . Biol Pharm Bull 2007; 30: 1965-1968
    CrossrefPubMedGoogle Scholar
  • 8 Kang KA, Zhang R, Piao MJ. Protective effect of irisolidone, a metabolite of kakkalide, against hydrogen peroxide induced cell damage via antioxidant effect. Bioorg Med Chem 2008; 16: 1133-1141
    CrossrefPubMedGoogle Scholar
  • 9 Bai X, Xie Y, Liu J, Qu J, Kano Y, Yuan D. Isolation and identification of urinary metabolites of kakkalide in rats. Drug Metab Dispos 2010; 38: 281-286
    CrossrefPubMedGoogle Scholar
  • 10 Bai X, Qu J, Lu J, Kano Y, Yuan D. Pharmacokinetics of kakkalide and its main metabolites in rat plasma determined by HPLC-DAD and LC–MSn . J Chromatogr B 2011; 879: 395-402
    CrossrefPubMedGoogle Scholar
  • 11 Yuan D, Xie YY, Bai X, Wu X, Yang JY, Wu CF. Inhibitory activity of isoflavones of Pueraria flowers on nitric oxide production from lipopolysaccharide-activated primary rat microglia. J Asian Nat Prod Res 2009; 11: 471-481
    CrossrefPubMedGoogle Scholar
  • 12 Chang X, Xie YY, Hu JL, Yuan D. Flavonoid constituents in the flowers of Pueraria thomsonii Benth. Chin J Med Chem 2009; 19: 284-287
    PubMedGoogle Scholar
  • 13 Bai X, Qu JL, Liu J, Sun JH, Yuan D. Isolation and identification of urinary metabolites of tectoridin in rats. J Asian Nat Prod Res 2011; 13: 604-610
    CrossrefPubMedGoogle Scholar
  • 14 Yang Z, Zhu W, Gao S, Xu HY, Wu BJ, Kulkarni K, Singh R, Tang L, Hu M. Simultaneous determination of genistein and its four phase II metabolites in blood by a sensitive and robust UPLC-MS/MS method: Application to an oral bioavailability study of genistein in mice. J Pharm Biomed Anal 2010; 53: 81-89
    CrossrefPubMedGoogle Scholar
  • 15 Hasselström J, Säwe J. Morphine pharmacokinetics and metabolism in humans. Clin Pharmacokinet 1993; 24: 344-354
    CrossrefPubMedGoogle Scholar
  • 16 Wong CK, Keung WM. Daidzein sulfoconjugates are potent inhibitors of sterol sulfatase. Biochem Biophys Res Commun 1997; 233: 579-583
    CrossrefPubMedGoogle Scholar
  • 17 Kinjo J, Tsuchihashi R, Morito K, Hirose T, Aomori T, Nagao T, Okabe H, Nohara T, Masamune Y. Interactions of phytoestrogens with estrogen receptors alpha and beta (III). Estrogenic activities of soy isoflavone aglycones and their metabolites isolated from human urine. Biol Pharm Bull 2004; 27: 185-188
    CrossrefPubMedGoogle Scholar
  • 18 Rüfer CE, Maul R, Donauer E, Fabian EJ, Kulling SE. In vitro and in vivo metabolism of the soy isoflavone glycitein. Mol Nutr Food Res 2007; 51: 813-823
    CrossrefPubMedGoogle Scholar